Get the Stockscreener App
0.1557
15.68%
-0.0306
Tevogen Bio Holdings Inc stock is traded at $0.1557, with a volume of 2.07M.
It is down -15.68% in the last 24 hours and down -43.95% over the past month.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
See More
Previous Close:
$0.1862
Open:
$0.18
24h Volume:
2.07M
Relative Volume:
2.22
Market Cap:
$31.46M
Revenue:
-
Net Income/Loss:
$52.50M
P/E Ratio:
5.3488
EPS:
0.0291
Net Cash Flow:
$-4.13M
1W Performance:
-45.75%
1M Performance:
-43.95%
6M Performance:
-81.88%
1Y Performance:
-86.81%
1-Day Range:
$0.1428
$0.1879
1-Week Range:
$0.1428
$0.2831
52-Week Range:
$0.1428
$1.51
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
Name
Tevogen Bio Holdings Inc
Sector
Industry
Phone
646-807-8832
Address
15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN
Compare TVGN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TVGN
Tevogen Bio Holdings Inc
|
0.1561 | 37.52M | 0 | 52.50M | -4.13M | 0.0291 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.31 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
763.30 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
722.13 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.25 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.71 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Initiated | D. Boral Capital | Buy |
Tevogen Bio Holdings Inc Stock (TVGN) Latest News
Tevogen eyes 11 FDA-approved generics in Apozeal deal talks - Stock Titan
Tevogen Announces Reverse Stock Split - Bitget
TVGN Downgrade: Analyst Shifts Rating from Buy to Hold | TVGN St - GuruFocus
Tevogen Shares Plunge 22% After Reverse Stock Split Announcement - Nasdaq
Tevogen Bio Announces 1-for-50 Reverse Stock Split - TipRanks
1-for-50 Reverse Split Effective Mar 6, 2026 — Tevogen (NASDAQ: TVGN) - Stock Titan
Tevogen Bio (Nasdaq: TVGN) sets 1-for-50 reverse stock split to meet Nasdaq bid rule - Stock Titan
Tevogen announces reverse stock split - marketscreener.com
TVGN: Analyst Lowers Price Target by 60% While Maintaining Buy R - GuruFocus
D. Boral Capital lowers Tevogen Bio stock price target to $2 on dilution risk - Investing.com
Tevogen Bio Signs Letter of Intent to Explore Contract Research Organization Acquisition - marketscreener.com
Tevogen Bio Holdings Inc. Signs Non-Binding Letter of Intent to Explore Potential Transaction with Global Contract Research Organization - Quiver Quantitative
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization - ChartMill
UPDATETevogen Signs Letter of Intent to Evaluate - GlobeNewswire
Tevogen signs loi to evaluate potential acquisition of Sciometrix - marketscreener.com
Tevogen (NASDAQ: TVGN) approves reverse split and 100M plan increase - Stock Titan
Tevogen Bio Holdings Inc. Signs Letter of Intent to Explore Acquisition of Sciometrix Inc. for Enhanced Healthcare Solutions | TVGN Stock News - Quiver Quantitative
Tevogen weighs Sciometrix digital health deal that could bring in revenue - Stock Titan
Tevogen Bio Shareholders Approve Reverse Split Authorization - TipRanks
Ryan Saadi: Innovative Biotech Leader, Tevogen Bio Founder and CEO, and Champion of Accessible Immunotherapy - BBN Times
TVGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Inflation Data: Is NESR stock a buy or sell2025 Investor Takeaways & Growth Focused Entry Reports - baoquankhu1.vn
Is Psyence Biomedical Ltds ROIC above industry averageJuly 2025 News Drivers & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Tevogen Bio (TVGN) to Release Earnings on Wednesday - MarketBeat
Is Tevogen Bio Holdings Inc. a defensive stockShare Buyback & Consistent Return Investment Signals - mfd.ru
What is Tevogen Bio Holdings Inc.’s valuation compared to sectorJuly 2025 Gainers & Long Hold Capital Preservation Plans - mfd.ru
Tevogen Bio (NASDAQ:TVGN) Trading 7.9% HigherShould You Buy? - MarketBeat
Tevogen Bio (NASDAQ:TVGN) Trading 7.9% Higher – Should You Buy? - Defense World
Can Tevogen Bio Holdings Inc. Equity Warrant expand its profit margins2025 Technical Patterns & Risk Adjusted Buy/Sell Alerts - mfd.ru
Will Tevogen Bio Holdings Inc. stock continue upward momentumMarket Movement Recap & Consistent Income Trade Ideas - mfd.ru
Aug Rallies: Can Tevogen Bio Holdings Inc Equity Warrant maintain its current growth rate2025 Earnings Impact & Daily Profit Focused Stock Screening - baoquankhu1.vn
How cyclical is Tevogen Bio Holdings Inc.’s revenue streamEarnings Performance Report & Capital Efficiency Focused Strategies - mfd.ru
What momentum indicators show for Tevogen Bio Holdings Inc. stockJuly 2025 WrapUp & Risk Controlled Swing Trade Alerts - mfd.ru
How risky is Tevogen Bio Holdings Inc. Equity Warrant stock nowTrade Volume Report & Fast Gain Stock Tips - mfd.ru
What are Tevogen Bio Holdings Inc.’s recent SEC filings showingWeekly Trade Review & Accurate Intraday Trading Signals - mfd.ru
Sentiment Review: Is CORT stock overvalued or fairly pricedJuly 2025 Action & High Accuracy Buy Signal Tips - baoquankhu1.vn
Why Tevogen Bio Holdings Inc. stock is a value investor pickJuly 2025 Analyst Calls & Real-Time Volume Analysis Alerts - mfd.ru
What’s the outlook for Tevogen Bio Holdings Inc.’s sectorJuly 2025 Weekly Recap & Stepwise Swing Trade Plans - mfd.ru
Can Tevogen Bio Holdings Inc. Equity Warrant maintain its current growth rateQuarterly Earnings Report & Daily Technical Forecast Reports - mfd.ru
Is now the right time to enter Tevogen Bio Holdings Inc. Equity WarrantJobs Report & Technical Analysis for Trade Confirmation - mfd.ru
Should I buy Tevogen Bio Holdings Inc. Equity Warrant stock nowJuly 2025 Outlook & AI Forecasted Stock Moves - mfd.ru
Does Tevogen Bio Holdings Inc. Equity Warrant meet Warren Buffett’s criteriaWeekly Profit Recap & Momentum Based Trading Signals - mfd.ru
How geopolitical tensions affect Tevogen Bio Holdings Inc. Equity Warrant stockJuly 2025 Market Mood & Weekly Chart Analysis and Trade Guides - mfd.ru
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders - BioSpace
Press Release: Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders - 富途牛牛
AI Stocks: Can Tevogen Bio Holdings Inc Equity Warrant maintain its current growth rateInsider Selling & Real-Time Buy Signal Alerts - baoquankhu1.vn
Tevogen board to evaluate potential special cash dividend By Investing.com - Investing.com India
VIX Spike: Can ADAG generate free cash flowQuarterly Investment Review & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Tevogen Evaluates Potential Special Cash Dividend - Intellectia AI
Tevogen Bio Holdings Inc Evaluates Special Cash Dividend - TradingView
Tevogen board to evaluate potential special cash dividend - Investing.com
Tevogen Bio Holdings Inc Stock (TVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.07%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):